Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

UV Voices Kamerkoor by die KKNK
2005-03-10

Membra Jesu nostri – Buxtehude (1637 – 1707)
 

Membra Jesu nostri patientis sanctissima (Die allerheilige liggaam van die lydende Jesus aan die kruis) deur Buxtehude het die Kruisiging van Jesus as tema.

Die uurlange werk word in Latyn gesing en handel in elk van die sewe dele oor ‘n deel van Jesus se liggaam aan die kruis: voete, knië, hande, die sy, bolyf, hart en gesig. Voices Inc – Kovsie kamerkoor word bygestaan deur die Odeion Strykkwartet met Francois Henkins, Abrie de Wet, John Wille en Michaela Haller. Die kontrabas word deur Alba Henkins-Molller bespeel en Jan Beukes is die orrelis.

Die woorde in Latyn wat buitengewoon was vir ‘n werk deur Buxtehude, is geneem uit die Latynse Bybel (Vulgate) en van die Rhytmica Oratio Sancti Bernadi, ‘n strofiese gedig deur St Bernard van Claivaux (c1090 – 1153).

Die wyse waarop Jesus se pyn aan die kruis uitgebeeld word asook die gebed en uitroep van versoening tussen God en die mensdom was deel van die Piëtiste se oortuigings van die tyd.

Die werk is saamgestel uit sewe afsonderlike dele wat telkens deur ‘n instrumentale sonate aangekondig word. Die koor lui die vokale bydrae in en sluit elke deel ook af. Die res van die werk bestaan uit verskillende groeperings van solo’s en trio’. Interessante vokale kombinasies kan gehoor word, bv. twee soprane en bas asook sopraan, alt en tenoor.

Hierdie opwindende aanbieding van Membra Jesu nostri, ‘n juweel uit die Baroktydperk, word aangebied deur ‘n groep energieke studente van Kovsies. Die jeugdige klank van die soliste – almal studente aan die Universiteit van die Vrystaat - dra by tot die egtheid van die Barok-klank. Die koor staan onder leiding van Leona Geldenhuys, dosent in Koorleiding aan die UV.

Optreedatums in die Moederkerk op Oudtshoorn. is:

 

  • Vrydag 25 Maart om 19:00
  • Saterdag 26 Maart om 13:00
  • Sondag 27 Maart om 19:00
  • Maandag 28 Maart om 16:00
  • Dinsdag 29 Maart om 10:00

Toegang is R50,00

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept